These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35946376)

  • 21. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equine Herpesvirus-I Infection in Horses: Recent Updates on its Pathogenicity, Vaccination, and Preventive Management Strategies.
    Khusro A; Aarti C; Rivas-Caceres RR; Barbabosa-Pliego A
    J Equine Vet Sci; 2020 Apr; 87():102923. PubMed ID: 32172913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
    Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the molecular detection of vaccine-derived equine herpesvirus type 1 in blood and nasal secretions from horses following intramuscular vaccination.
    Pusterla N; Chaney KP; Maes R; Wise AG; Holland R; Schott HC
    J Vet Diagn Invest; 2007 May; 19(3):290-3. PubMed ID: 17459860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
    Patel JR; Heldens J
    Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune and Inflammatory Response in Horse Vaccinated Against Equine Herpesviruses 1 (EHV-1) and 4 (EHV-4) Assessed by Serum Protein Electrophoretic Pattern and Leukocyte Population.
    Giannetto C; Giudice E; Piccione G; Castronovo C; Arfuso F
    J Equine Vet Sci; 2022 Sep; 116():104051. PubMed ID: 35753636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
    Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
    Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR; Bateman H; Williams J; Didlick S
    Vet Microbiol; 2003 Jan; 91(1):23-39. PubMed ID: 12441229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine.
    Yasunaga S; Maeda K; Matsumura T; Kondo T; Kai K
    J Vet Med Sci; 2000 Jul; 62(7):687-91. PubMed ID: 10945284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the Systemic Antibody Response and Antigen Detection Following Intranasal Administration of Two Commercial Equine Herpesvirus-1 Vaccines to Adult Horses.
    Spann K; Barnum S; Pusterla N
    J Equine Vet Sci; 2023 Mar; 122():104229. PubMed ID: 36657628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
    Foote CE; Love DN; Gilkerson JR; Whalley JM
    Vet Microbiol; 2002 Aug; 88(1):13-25. PubMed ID: 12119135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loop-mediated isothermal amplification assays for detection of Equid herpesvirus 1 and 4 and differentiating a gene-deleted candidate vaccine strain from wild-type Equid herpesvirus 1 strains.
    Nemoto M; Tsujimura K; Yamanaka T; Kondo T; Matsumura T
    J Vet Diagn Invest; 2010 Jan; 22(1):30-6. PubMed ID: 20093679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.
    Heldens JG; Kersten AJ; Weststrate MW; van den Hoven R
    Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.